Albert David

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE155C01010
  • NSEID: ALBERTDAVD
  • BSEID: 524075
INR
710.05
0.1 (0.01%)
BSENSE

Jun 17

BSE+NSE Vol: 534

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Jenburkt Pharma
Medico Remedies
Bafna Pharma.
Zim Laboratories
Valiant Laborato
Haleos Labs Limi
Albert David
CCME Global
Aptus Pharma
Transchem
Influx Health.
Why is Albert David Ltd ?
1
Poor long term growth as Operating profit has grown by an annual rate -182.99% of over the last 5 years
2
Flat results in Mar 26
  • PAT(Q) At Rs -21.43 cr has Fallen at -107.5%
  • EPS(Q) Lowest at Rs -37.53
3
Stock is technically in a Mildly Bearish range
  • Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
4
Risky - Negative Operating Profits
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -9.41%, its profits have fallen by -108.7%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Albert David for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Albert David
-15.73%
-0.27
34.63%
Sensex
-5.06%
-0.49
12.94%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
6.16%
EBIT Growth (5y)
-182.99%
EBIT to Interest (avg)
20.46
Debt to EBITDA (avg)
0.13
Net Debt to Equity (avg)
-0.62
Sales to Capital Employed (avg)
0.98
Tax Ratio
100.00%
Dividend Payout Ratio
16.59%
Pledged Shares
0
Institutional Holding
2.24%
ROCE (avg)
20.77%
ROE (avg)
11.69%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
34
Price to Book Value
1.03
EV to EBIT
-37.76
EV to EBITDA
29.74
EV to Capital Employed
1.08
EV to Sales
0.49
PEG Ratio
NA
Dividend Yield
0.70%
ROCE (Latest)
-13.46%
ROE (Latest)
-0.38%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company
Icon
NO KEY POSITIVE TRIGGERS
-4What is not working for the Company
PAT(Q)

At Rs -21.43 cr has Fallen at -107.5%

EPS(Q)

Lowest at Rs -37.53

Loading Valuation Snapshot...
Here's what is not working for Albert David
Profit After Tax (PAT) - Quarterly
At Rs -21.43 cr has Fallen at -107.5%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Lowest at Rs -37.53
in the last five quarters
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (Rs)